Cefepime is typically administered intravenously or intramuscularly. The dosage and frequency depend on the severity of the infection, the patient's renal function, and other individual factors. For cancer patients, it is often given in higher doses or more frequently to ensure efficacy, especially if they are at high risk for severe infections.